|
KLHL7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.756000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.219700E-03 |
| Normal-vs-Stage2 |
3.567800E-01 |
| Normal-vs-Stage3 |
2.517800E-03 |
| Normal-vs-Stage4 |
5.51340000000122E-05 |
| Stage1-vs-Stage2 |
2.729000E-01 |
| Stage1-vs-Stage3 |
4.980400E-01 |
| Stage1-vs-Stage4 |
5.332000E-02 |
| Stage2-vs-Stage3 |
1.524570E-01 |
| Stage2-vs-Stage4 |
2.322300E-02 |
| Stage3-vs-Stage4 |
2.260400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.718700E-03 |
| Normal-vs-AfricanAmerican |
2.038400E-01 |
| Normal-vs-Asian |
7.610100E-04 |
| Caucasian-vs-AfricanAmerican |
6.213000E-01 |
| Caucasian-vs-Asian |
3.430200E-01 |
| AfricanAmerican-vs-Asian |
2.998000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.137400E-03 |
| Normal-vs-Female |
1.116600E-03 |
| Male-vs-Female |
9.004400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.942400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.383200E-04 |
| Normal-vs-Age(61-80Yrs) |
9.829700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.173200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.094200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.408780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.222000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.402200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.610800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.584800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.933400E-01 |
| Classical-VS-Follicular |
8.816000E-01 |
| Classical-VS-Other |
9.279400E-01 |
| Classical-VS-Normal |
7.155200E-03 |
| Tall-VS-Follicular |
7.829600E-01 |
| Tall-VS-Other |
7.664200E-01 |
| Tall-VS-Normal |
2.920000E-02 |
| Follicular-VS-Other |
9.137800E-01 |
| Follicular-VS-Normal |
3.470000E-02 |
| Other-VS-Normal |
3.351200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.357060E-03 |
| Normal-vs-N1 |
4.380500E-04 |
| N0-vs-N1 |
3.201000E-01 |
|
|
